LNX1 anticorps (C-Term)
Aperçu rapide pour LNX1 anticorps (C-Term) (ABIN630139)
Antigène
Voir toutes LNX1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- LNX1 antibody was raised against the C terminal of LNX1
-
Purification
- Purified
-
Immunogène
- LNX1 antibody was raised using the C terminal of LNX1 corresponding to a region with amino acids SHREWDLPIYVISVEPGGVISRDGRIKTGDILLNVDGVELTEVSRSEAVA
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
LNX1 Blocking Peptide, (ABIN5614479), is also available for use as a blocking control in assays to test for specificity of this LNX1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LNX1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LNX1 (Ligand of Numb-Protein X 1 (LNX1))
-
Autre désignation
- LNX1
-
Sujet
- LNX1 is a membrane-bound protein that is involved in signal transduction and protein interactions. LNX1 is an E3 ubiquitin-protein ligase, which mediates ubiquitination and subsequent proteasomal degradation of proteins containing phosphotyrosine binding (PTB) domains. This protein may play an important role in tumorogenesis.
-
Poids moléculaire
- 70 kDa (MW of target protein)
Antigène
-